Two new analyses of the Multi-Ethnic Study of Atherosclerosis (MESA) provide evidence that the use of coronary artery calcium (CAC) screening can reclassify patients at risk from cardiovascular disease and better identify those who would most benefit from statin therapy compared with current guidelines.
For patients with first-time unprovoked venous thromboembolism (VTE), oral sulodexide may help stave off future flare-ups without causing serious safety risks, suggests new research published online September 25, 2015 in Circulation..
Alendronate may have a beneficial effect on muscle mass in addition to its well known positive effect on bone mass, hint preliminary findings from Japan. According to Dr. Atsushi Harada from the National Center for Geriatrics & Gerontology in Aichi, there is growing evidence of a functional musclebone unit in which bone health may be […]
The use of insulin pumps in patients with difficult-to-treat type 2 diabetes is safe and effective for up to 5 years, a small single-center study suggests. The findings were presented September 17 here at the European Association for the Study of Diabetes (EASD) 2015 Meeting by Priyamvada Singh, MD, of St Vincent Hospital, Worcester, Massachusetts.
The National Academy of Medicine, last week released “Improving Diagnosis in Health Care,” a report that addresses diagnostic errors in health care. The report summarizes the evidence on this broad, system-wide problem and outlines recommendations to make diagnosis more accurate, reliable, efficient, and safe.
One in eight young women with acute Myocardial Infarction (MI) have a type of MI that falls in the “unclassified” category under a current classification system, researchers report; they propose a new taxonomy that better captures different presentations in young women.
The US Preventive Services Task Force (USPSTF) advised in its final recommendation statement on smoking cessation in adults that clinicians should ask all adults about their tobacco use, advise them to quit if they do smoke, and provide evidence-based behavioral therapies and medications to help them quit.
The American College of Cardiology, American Heart Association, and the Heart Rhythm Society (ACC/AHA/HRS) have published new guidelines for the management of patients with supraventricular tachycardia (SVT).
The European Medicines Agency (EMA) has recommended the approval a specific antidote to reverse the anticoagulant effect of the direct oral thrombin inhibitor dabigatran (Pradaxa): idarucizumab (Praxbind, Boehringer Ingelheim).
According a new research, overingestion of two factor Xa inhibitors is rarely associated with serious bleeding in adults — and has no association with toxicity in kids who accidently take the drugs.